Your best medicine news resource
Nov 21st 2008Drug InformationADHD
In contrast to recent findings, two of the most common medications used to treat attention deficit hyperactivity disorder (ADHD) do not appear to cause genetic damage in children who take them as prescribed, according to a new study by researchers at the National Institutes of Health (NIH) and Duke University Medical Center.
More: continued here
Nov 21st 2008Drug InformationADHD
The US Food and Drug Administration (FDA) has approved a 30-minute onset of action for Focalin(R) XR (dexmethylphenidate HCl) extended-release capsules for the treatment of Attention Deficit/Hyperactivity Disorder (ADHD), bringing potential benefits for young patients and their families during the important morning period when they are preparing for school.
More: continued here
Nov 11th 2008Drug InformationADHD
New research published on bmj.com explores the relationship between head injuries and attention deficit hyperactivity disorder (ADHD). Although there is not enough evidence to state that head injuries in young children cause ADHD, researchers have found that early head injury is indeed associated with a subsequent diagnosis of ADHD.
More: continued here
Your best medicine news resource
